Status new methods

CIPAC Methods, when proposed by a company or an organization get a first status (draft method) when they are discussed in a CIPAC Meeting. After having been accepted, they receive the status "provisional" in a following CIPAC Meeting, and finally they are accepted as full methods.

In addition, methods may be revised, especially in case of CIPAC MT's. Release of revised methods follow the same procedure by CIPAC. 


DAPF document: Summary of New & Revised CIPAC MT methods
The purpose of the doucment was created and is maintained by DAPF to provide an overview of actual and older/superseded versions of MT methods. 
This document is published on the CIPAC website as CIPAC sees the benefit to support registration applicants, authorities and regulatory bodies as well as control labs on the status of the most recent methods and versions. CIPAC is encouraging the use of the actual methods & versions. However, the German DAPF has created it and is fully responsible for its content and any amendment.
Further information about the German DAPF you find here.

DownloadSummary of new & revised MT methods by DAPF


Decisions of the 66th CIPAC virtual meeting June 2022
The table "Decisions of the 66th CIPAC Meeting" presented below the methods which are either accepted as provisional or full methods.


CIPAC no /
Name
Description
Status
Published
1006
28-homobrassinolide
The reversed phase HPLC method (CIPAC/5269) for the
determination of 28-homobrassinolide in TC, SL and EC
formulations was accepted as a full CIPAC method.
Full
133
Ametryn
The capillary GC method using internal standard (CIPAC/5265)
for the determination of ametryn in TC, WG and SC formulations
was accepted as a full CIPAC method.
Full
221
Chlorpyrifos
The reversed phase HPLC method (CIPAC/5277) for the
determination of chlorpyrifos in TC and EC formulations was
accepted as a full CIPAC method.
Full
494
Tebuconazole
The extension of the scope (CIPAC/5287) of CIPAC method
494/WP/M/3 for the determination of the tebuconazole content
in EC formulations was accepted as a full CIPAC method.

Full
No
xx
14-hydroxylated brassinosteroid
The reversed phase HPLC method (CIPAC/5311) for the determination
of 14-hydroxylated brassinosteroid in TK and SL formulations was
accepted as provisional CIPAC method with additional justification for
the Horrat >1 and for the eliminations.
Provisional
No
687
Difenoconazole
The capillary gas chromatographic method with split injection, using
1,3,5-triphenylbenzene as internal standard (CIPAC/5324), for the
determination of difenoconazole in TC, EC and WG formulations was
accepted as provisional CIPAC method considering the data sets
using hydrogen or helium as eluent gas with the need for a stricter
description of the method.
Provisional
No
373
Ethephon
The ion-chromatographic  method (CIPAC/5315) for the determination
of ethephon in TC, TK and SL formulations was accepted as provisional
CIPAC method, without the need to eliminate outliers in the case of TC samples.
Provisional
No
578
Flumioxazin
The extension of the reversed phase HPLC method 578 (CIPAC/5330)
to the determination of flumioxazin in SC and WG formulations
was accepted as provisional CIPAC method.
Provisional
No
xxx
Matrine
The reversed phase HPLC method (CIPAC/5313) for the determination
of matrine in TK and SL formulations was accepted as
provisional CIPAC method.
Provisional
No
414
Methoprene
The extension of the reversed phase HPLC method 414 (CIPAC/5305) to the
determination of methoprene in GR, GR-SB and CS formulations was accepted
as provisional CIPAC method.
Provisional
No
239
Pirimiphos-methyl
The extension of the gas chromatographic method 239 (CIPAC/5301) to the
determination of pirimiphos-methyl in LN formulations was accepted
as provisional CIPAC method.
Provisional
No
183
Trifuralin
The reversed phase HPLC method (CIPAC/5303) for the determination of trifluralin
in TC and EC formulations was accepted as provisional CIPAC method.
Provisional
No
333 + 570
Deltamethrin + chlorfenapyr
The normal phase HPLC method (CIPAC/5297) for the determination of deltamethrin
in TC, chlorfenapyr in TC and deltamethrin + chlorfenapyr in LN formulations was
accepted as provisional CIPAC method with the need to modify the description
of the method considering the column and specifying the resolution.
Provisional
No
MT 178.3
Attirion resistance
The revision of methods MT 178 and MT 178.2  (CIPAC/5321) to combine into a single
method for granular products and to include loosely packed tablets was accepted as provisional CIPAC method with the editorial changes and with the remark that
MT 178.3 supersedes MT 178 and MT 178.2.
Provisional
No
MT XXX
Discharge rate of trigger dispenser
The method for determination of the discharge rate of trigger dispensers (CIPAC/5152)
was accepted as provisional CIPAC method with  the need for further clarifications
from DAPF considering packaging types.
Provisional
No
MT XXX
Discharge rate of aerosol dispenser
The method for determination of the discharge rate of aerosol dispenser (CIPAC/5153)
was accepted as provisional CIPAC method.
Provisional
No
MT 160.1
Spontaneity of dispersion of suspension concentrates
The revision of methods MT 160 (CIPAC/5323) to determine the spontaneity of
dispersion of liquid formulations forming suspensions on dilution with water
was accepted as provisional CIPAC method with the remark that MT 160.1 supersedes MT 160.
Provisional
No